🇺🇸 SOTROVIMAB in United States

3,105 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Exposure During Pregnancy — 1,350 reports (43.48%)
  2. Infusion Related Reaction — 277 reports (8.92%)
  3. Off Label Use — 267 reports (8.6%)
  4. Product Storage Error — 259 reports (8.34%)
  5. Covid-19 — 235 reports (7.57%)
  6. Pyrexia — 189 reports (6.09%)
  7. Nausea — 140 reports (4.51%)
  8. Dyspnoea — 139 reports (4.48%)
  9. Live Birth — 133 reports (4.28%)
  10. Drug Ineffective — 116 reports (3.74%)

Source database →

SOTROVIMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SOTROVIMAB approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for SOTROVIMAB in United States?

Marketing authorisation holder not available in our data.